Related Experiment Video
Updated: Jan 10, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Clinical presentation and outcomes of patients with biallelic SCN5A variants: A systematic review
Elodie Surget1,2, Alexis Hermida3, Alice Maltret4
1Reference Center for Inherited Arrhythmic Syndromes, Hôpital Bichat, APHP, Université Paris Cité, Paris, France.
Insights
Biallelic SCN5A variants cause severe early-onset arrhythmias and high mortality. Non-missense variants are linked to worse outcomes, emphasizing the need for early diagnosis and management in this rare population.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Heterozygous SCN5A variants are linked to inherited arrhythmias.
- Clinical phenotypes of biallelic (homozygous or compound heterozygous) SCN5A variants are poorly understood.
Purpose of the Study:
- To systematically review clinical characteristics, outcomes, and genotype-phenotype correlations in patients with biallelic SCN5A variants.
Main Methods:
- Systematic literature review of 33 articles involving 61 patients.
- Evaluation of demographic data, medical history, prognosis, and genotype-phenotype correlations.
Main Results:
- Most patients (81%) were symptomatic, presenting with syncope or cardiac arrest.
- Sinus node dysfunction (65%) and progressive cardiac conduction disease (33%) were common phenotypes.
- Non-missense variants correlated with earlier onset and increased risk of major cardiac events, with 50% experiencing major cardiac events and 15% dying young.
Conclusions:
- Biallelic SCN5A variants lead to severe, early-onset arrhythmias with high morbidity and mortality.
- Improved recognition and international collaboration are crucial for optimizing diagnosis and management.
- Non-missense variants indicate a poorer prognosis, necessitating targeted interventions.
Background:
Heterozygous SCN5A variants are associated with a wide spectrum of inherited arrhythmic disorders. However, little is known about the clinical phenotypes associated with biallelic (ie, homozygous or compound heterozygous) SCN5A variants.
Objective:
The purpose of this study was to systematically review the clinical characteristics, outcomes, and genotype-phenotype correlations in patients with biallelic SCN5A variants.
Methods:
We reviewed the available literature on patients with biallelic SCN5A variants and evaluated their demographic characteristics, medical history, and prognosis.
Results:
A total of 33 articles were selected, comprising 61 patients from 43 families. Most were symptomatic at diagnosis (29/36, 81%), with common presentations including syncope (15/36, 42%) and cardiac arrest (10/36, 28%). Sinus node dysfunction was the most prevalent phenotype (35/54, 65%), often associated with atrial standstill (20/34, 59%). Other electrocardiographic abnormalities included progressive cardiac conduction disease (17/52, 33%), Brugada syndrome (12/52, 23%), overlap phenotypes (7/52, 13%), and long QT syndrome (2/52, 4%). During follow-up (median 5 ± 7 years), arrhythmias were common, and 76% (39/51) of patients required device implantation. Major cardiac events occurred in 50%, and 15% (8/55) died at a young age (mean 9 ± 15 years). Genotype analysis revealed 21 patients with homozygous SCN5A variants (34%) and 40 with compound heterozygous variants (66%). The type of variant, rather than zygosity, correlated with prognosis: a non-missense variant was associated with earlier onset and increased risk of major cardiac events.
Conclusion:
Patients with biallelic SCN5A variants display early-onset severe arrhythmic phenotypes with high morbidity and mortality. Improved recognition and international collaboration are essential to optimize diagnosis, management, and prevention of sudden cardiac death in this rare but high-risk population.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Mitral Stenosis II: Clinical features and Diagnostic Tests
Single Nucleotide Polymorphisms-SNPs

